In a filing, Nutex Health Inc. revealed its Chief Executive Officer Vo Thomas T. acquired Company’s shares for reported $42651.0 on Aug 31. In the deal valued at $0.28 per share,152,326 shares were bought. As a result of this transaction, Vo Thomas T. now holds 269,322,776 shares worth roughly $ 75.41 million.
Then, Vo Thomas T. bought 305,947 shares, generating $94,844 in total proceeds. Upon buying the shares at $0.31, the Chief Executive Officer now owns 269,170,450 shares.
Before that, Vo Thomas T. bought 342,744 shares. Nutex Health Inc. shares valued at $102,823 were divested by the Chief Executive Officer at a price of $0.30 per share. As a result of the transaction, Vo Thomas T. now holds 268,864,503 shares, worth roughly $75.28 million.
Northland Capital initiated its Nutex Health Inc. [NUTX] rating to an Outperform in a research note published on Friday, February 22, 2023; the price target was $3. PT values the company’s stock at a premium of 90.67 to its Friday closing price.
Price Performance Review of NUTX
On Friday, Nutex Health Inc. [NASDAQ:NUTX] saw its stock jump 0.04% to $0.28. On the same session, the stock had its day’s lowest price of $0.2665, but rose to a high of $0.2855. Over the last five days, the stock has lost -0.36%. Nutex Health Inc. shares have fallen nearly -85.42% since the year began. Nevertheless, the stocks have fallen -89.70% over the past one year. While a 52-week high of $4.05 was reached on 01/04/23, a 52-week low of $0.26 was recorded on 08/24/23. SMA at 50 days reached $0.3739, while 200 days put it at $0.9494. A total of 4.67 million shares were traded, compared to the trading of 1.66 million shares in the previous session.
Levels Of Support And Resistance For NUTX Stock
The 24-hour chart illustrates a support level at 0.2672, which if violated will result in even more drops to 0.2573. On the upside, there is a resistance level at 0.2862. A further resistance level may holdings at 0.2953. The Relative Strength Index (RSI) on the 14-day chart is 36.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0116, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.48%. Stochastics %K at 25.62% indicates the stock is a holding.
How much short interest is there in Nutex Health Inc.?
A steep rise in short interest was recorded in Nutex Health Inc. stocks on Aug 14, 2023, dropping by -1.04 million shares to a total of 3.4 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 4.44 million shares. There was a decline of -30.59%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.98% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.24.
Nutex Health Inc. [NUTX] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 9,478,085 shares, or roughly 1.43% of the outstanding NUTX shares. In other words, the investor’s shares have fallen by -444,993 from its previous 13-F filing of 9923078.0. Additionally, Truist Bank increased 858.72% of its stake after which the total value it holdings stand at $1,441,411. Over the last quarter, MAI Capital Management LLC purchased 822,971 shares of Nutex Health Inc., while Balyasny Asset Management LP bought 1,190,186 shares. At present, Beaird Harris Wealth Management L is holding 928,050 shares valued at $0.39 million. Goldman Sachs & Co. LLC owned 901,037 shares of the company at the time of its most recent 13F filing, worth $0.38 million.
According to FactSet, Nutex Health Inc.’s share price will average $2.38 in the next year, based on opinions of analysts polled by the firm. This is up nearly 750.0 percent from its previous closing price of $0.28. Analysts expect Nutex Health Inc. stock to reach the higher price of $2.50, while the lowest price estimate is $2.25. However, 2 analysts have rated NUTX stock as a Buy in their predictions for 2023.